Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 227
Filter
1.
Ophthalmologe ; 116(2): 201-212, 2019 Feb.
Article in German | MEDLINE | ID: mdl-30715591

ABSTRACT

Approximately 500,000 blind and 1 million visually impaired persons live in Germany, which lacks a national blind registry. Therefore data from social welfare agencies and population-based studies are used to estimate prevalence and incidence. Main causes for severe visual impairment and blindness are age-related macular degeneration, glaucoma and diabetic eye diseases. We observed a relative decline of the incidence of severe visual impairment and blindness over the last decades, which is primarily due to improved ophthalmic care and better treatment options. However, the absolute number of subjects with severe visual impairment and blindness increases due to population ageing. This will cause significant social and economic challenges in the future.


Subject(s)
Blindness , Visually Impaired Persons , Age Distribution , Germany , Humans , Prevalence , Vision Disorders , Visual Acuity
2.
J Clin Monit Comput ; 30(6): 797-805, 2016 Dec.
Article in English | MEDLINE | ID: mdl-26424541

ABSTRACT

Altered respiratory rate is one of the first symptoms of medical conditions that require timely intervention, e.g., sepsis or opioid-induced respiratory depression. To facilitate continuous respiratory rate monitoring on general hospital wards a contactless, non-invasive, prototype monitor was developed using frequency modulated continuous wave radar. We aimed to study whether radar can reliably measure respiratory rate in postoperative patients. In a diagnostic cross-sectional study patients were monitored with the radar and the reference monitor (pneumotachograph during mechanical ventilation and capnography during spontaneous breathing). Eight patients were included; yielding 796 min of observation time during mechanical ventilation and 521 min during spontaneous breathing. After elimination of movement artifacts the bias and 95 % limits of agreement for mechanical ventilation and spontaneous breathing were -0.12 (-1.76 to 1.51) and -0.59 (-5.82 to 4.63) breaths per minute respectively. The radar was able to accurately measure respiratory rate in mechanically ventilated patients, but the accuracy decreased during spontaneous breathing.


Subject(s)
Monitoring, Physiologic/methods , Radar , Respiration, Artificial/methods , Respiratory Rate , Adult , Algorithms , Artifacts , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Movement , Postoperative Period , Reproducibility of Results , Respiration , Respiratory Insufficiency , Signal Processing, Computer-Assisted , Wireless Technology
3.
J Nutr Health Aging ; 18(5): 496-502, 2014 May.
Article in English | MEDLINE | ID: mdl-24886736

ABSTRACT

OBJECTIVE: Nuts contain nutrients that may benefit brain health; thus, we examined long-term intake of nuts in relation to cognition in older women. DESIGN: Population-based prospective cohort study. SETTING: Academic research using data from the Nurses' Health Study. PARTICIPANTS: Nut intake was assessed in a food-frequency questionnaire beginning in1980, and approximately every four years thereafter. Between 1995-2001, 16,010 women age 70 or older (mean age = 74 years) without a history of stroke were administered 4 repeated telephone-based cognitive interviews over 6 years. Our final sample included 15,467 women who completed an initial cognitive interview and had complete information on nut intake. MAIN OUTCOME MEASURES: The Telephone Interview for Cognitive Status (TICS), a global score averaging the results of all tests (TICS, immediate and delayed verbal recall, category fluency, and attention), and a verbal memory score averaging the results of tests of verbal recall. RESULTS: In multivariable-adjusted linear regression models, higher long-term total nut intake was associated with better average cognitive status for all cognitive outcomes. For the global composite score combining all tests, women consuming at least 5 servings of nuts/week had higher scores than non-consumers (mean difference=0.08 standard units, 95% confidence interval 0.00-0.15; p-trend=0.003). This mean difference of 0.08 is equivalent to the mean difference we find between women 2 years apart in age. Long-term intake of nuts was not associated with rates of cognitive decline. CONCLUSIONS: Higher nut intake may be related to better overall cognition at older ages, and could be an easily-modifiable public health intervention.


Subject(s)
Cognition/physiology , Diet/statistics & numerical data , Nuts , Aged , Attention/physiology , Cognition Disorders , Cohort Studies , Eating , Female , Health Surveys , Humans , Mental Recall/physiology , Nurses , Prospective Studies , Time Factors
4.
J Intern Med ; 275(3): 229-50, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24605807

ABSTRACT

BACKGROUND: Definitions and diagnostic criteria for all medical conditions are regularly subjected to reviews and revisions as knowledge advances. In the field of Alzheimer's disease (AD) research, it has taken almost three decades for diagnostic nomenclature to undergo major re-examination. The shift towards presymptomatic and pre-dementia stages of AD has brought prevention and treatment trials much closer to each other than before. METHODS: Here we discuss: (i) the impact of diagnostic reliability on the possibilities for developing preventive strategies for AD; (ii) the scientific evidence to support moving from observation to action; (iii) ongoing intervention studies; and (iv) the methodological issues and prospects for balancing strategies for high-risk individuals with those for broad population-based prevention. RESULTS: The associations between neuropathology and cognition are still not entirely clear. In addition, the risk factors for AD dementia and the neuropathological hallmarks of AD may not necessarily be the same. Cognitive impairment has a clearer clinical significance and should therefore remain the main focus of prevention. Risk/protective factors for dementia/AD need to be studied from a life-course perspective. New approaches in prevention trials include enrichment strategies based on genetic risk factors or beta-amyloid biomarkers (at least four ongoing pharmacological trials), and multidomain interventions simultaneously targeting various vascular and lifestyle-related risk factors (at least three ongoing trials). Experience from prevention programmes in other chronic diseases can provide additional methodological improvements. CONCLUSIONS: Building infrastructures for international collaborations is necessary for managing the worldwide public health problem of AD and dementia. The International Database on Aging and Dementia (IDAD) and the European Dementia Prevention Initiative (EDPI) are examples of ongoing international efforts aiming to improve the methodology of preventive studies and provide the basis for larger intervention trials.


Subject(s)
Alzheimer Disease , Dementia , Preventive Medicine/methods , Prodromal Symptoms , Aging , Alzheimer Disease/complications , Alzheimer Disease/diagnosis , Alzheimer Disease/prevention & control , Biomarkers/analysis , Clinical Trials as Topic , Cognition , Dementia/diagnosis , Dementia/etiology , Dementia/prevention & control , Early Diagnosis , Humans , Longitudinal Studies , Risk Factors
5.
Mol Psychiatry ; 19(12): 1326-35, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24535457

ABSTRACT

Amyloid beta (Aß) peptides are the major components of senile plaques, one of the main pathological hallmarks of Alzheimer disease (AD). However, Aß peptides' functions are not fully understood and seem to be highly pleiotropic. We hypothesized that plasma Aß peptides concentrations could be a suitable endophenotype for a genome-wide association study (GWAS) designed to (i) identify novel genetic factors involved in amyloid precursor protein metabolism and (ii) highlight relevant Aß-related physiological and pathophysiological processes. Hence, we performed a genome-wide association meta-analysis of four studies totaling 3 528 healthy individuals of European descent and for whom plasma Aß1-40 and Aß1-42 peptides levels had been quantified. Although we did not observe any genome-wide significant locus, we identified 18 suggestive loci (P<1 × 10(-)(5)). Enrichment-pathway analyses revealed canonical pathways mainly involved in neuronal functions, for example, axonal guidance signaling. We also assessed the biological impact of the gene most strongly associated with plasma Aß1-42 levels (cortexin 3, CTXN3) on APP metabolism in vitro and found that the gene protein was able to modulate Aß1-42 secretion. In conclusion, our study results suggest that plasma Aß peptides levels are valid endophenotypes in GWASs and can be used to characterize the metabolism and functions of APP and its metabolites.


Subject(s)
Aging/blood , Aging/genetics , Amyloid beta-Peptides/blood , Peptide Fragments/blood , Amyloid beta-Protein Precursor/genetics , Amyloid beta-Protein Precursor/metabolism , Genome-Wide Association Study , HEK293 Cells , Humans , Membrane Proteins/genetics , Membrane Proteins/metabolism , Polymorphism, Single Nucleotide , White People/genetics
6.
Transl Psychiatry ; 4: e358, 2014 Feb 04.
Article in English | MEDLINE | ID: mdl-24495969

ABSTRACT

To follow-up loci discovered by the International Genomics of Alzheimer's Disease Project, we attempted independent replication of 19 single nucleotide polymorphisms (SNPs) in a large Spanish sample (Fundació ACE data set; 1808 patients and 2564 controls). Our results corroborate association with four SNPs located in the genes INPP5D, MEF2C, ZCWPW1 and FERMT2, respectively. Of these, ZCWPW1 was the only SNP to withstand correction for multiple testing (P=0.000655). Furthermore, we identify TRIP4 (rs74615166) as a novel genome-wide significant locus for Alzheimer's disease risk (odds ratio=1.31; confidence interval 95% (1.19-1.44); P=9.74 × 10(-)(9)).


Subject(s)
Alzheimer Disease/genetics , Genetic Predisposition to Disease , Genome-Wide Association Study , Transcription Factors/genetics , Follow-Up Studies , Genetic Loci/genetics , Humans , Polymorphism, Single Nucleotide/genetics , Spain
7.
Age (Dordr) ; 35(2): 431-8, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22170281

ABSTRACT

There are indications that in persons of older age, systolic blood pressure (SBP) is no longer associated with mortality. This raises the question whether the predictive value of SBP changes from younger to older age groups. Analysis in the Rotterdam Study, a population-based prospective cohort study among 4,612 participants aged ≥55 years without previous cardiovascular disease and with a median follow-up of 14.9 (interquartile range, 11.1-15.8) years. Within four age groups (55-64, 65-74, 75-84, ≥85 years), the predictive value of baseline SBP for mortality was studied. From age 55 to ≥85 years, risk of all-cause mortality associated with SBP ≥160 mmHg decreased from HR 1.7 (95%CI 1.2-2.2) to HR 0.7 (95%CI 0.4-1.1), p for trend <0.001. For participants with SBP 140-159 mmHg, the risk decreased from HR 1.2 (95%CI 0.9-1.5) to HR 0.7 (95%CI 0.5-1.1), p for trend <0.001. Analyses in the 5-year age groups showed an increased risk with higher SBPs up to age 75 years. After 75 years, a trend towards SBP no longer being associated with an increased mortality risk was seen in our study. These findings need to be considered with recently reported beneficial effects of antihypertensive treatment in this age group.


Subject(s)
Aging/physiology , Hypertension/mortality , Hypertension/physiopathology , Mortality/trends , Systole/physiology , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Netherlands/epidemiology , Predictive Value of Tests , Prospective Studies , Risk Assessment
8.
Gait Posture ; 37(4): 500-5, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23018028

ABSTRACT

Poor gait is an important risk factor for falls and associated with higher morbidity and mortality. It is well established that older age is associated with worse gait, but it remains unclear at what age this association is first seen. Moreover, previous studies focused mainly on normal walking, but gait also encompasses turning and tandem walking. In a large study of community-dwelling middle-aged and elderly persons we investigated the association of age with gait, focusing on normal walking, turning and tandem walking. In 1500 persons aged 50 years and over, we measured gait using an electronic walkway. Participants performed normal walks, turning and a tandem walk. With principal components analysis of 30 variables we summarized gait into five known gait factors: Rhythm, Variability, Phases, Pace and Base of Support; and uncovered two novel gait factors: Tandem and Turning. The strongest associations with age were found for Variability (difference in Z-score -0.29 per 10 years increase (95% confidence interval: -0.34; -0.24)), Phases (-0.31 per 10 years (-0.36; -0.27)) and Tandem (-0.25 per 10 years (-0.30; -0.20)). Additionally, these factors already showed association with the youngest age groups, from 55 to 60 years of age and older. Our study shows that Variability, Phases and Tandem have the strongest association with age and are the earliest to demonstrate a poorer gait pattern with higher age. Future research should further investigate how these gait factors relate with gait-related diseases in their earliest stages.


Subject(s)
Aging/physiology , Gait/physiology , Accidental Falls , Age Distribution , Aged , Arthritis/epidemiology , Arthritis/physiopathology , Cohort Studies , Female , Humans , Male , Middle Aged , Netherlands/epidemiology , Risk Factors
9.
Neuroimage ; 63(4): 1782-9, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22960084

ABSTRACT

Hippocampal atrophy on MRI and changes in diffusion tensor imaging (DTI) measures of the hippocampus have been reported in patients with Alzheimer's disease. We examined the association between hippocampal volumes, DTI measures of the hippocampus and memory performance in 892 non-demented persons (age ≥ 55 years) across different age groups. Hippocampal volume was segmented on 3D volumetric MRI scans. The segmentations were co-registered to mean diffusivity (MD) and fractional anisotropy (FA) maps to yield mean hippocampal MD and FA measurements. Higher MD of the hippocampus was associated with impaired verbal memory performance. In all persons ≥ 55 years, a higher MD of the hippocampus was associated with a worse memory performance. Hippocampal volumes were very weakly positively associated with delayed recall and only in persons > 65 years. FA of the hippocampus was not associated with memory performance. Follow-up studies will be needed to determine whether higher MD of hippocampus at younger ages could be an earlier marker of incident Alzheimer's disease than hippocampal volume.


Subject(s)
Hippocampus/physiology , Memory/physiology , Psychomotor Performance/physiology , Aged , Aged, 80 and over , Aging/physiology , Aging/psychology , Cohort Studies , Data Interpretation, Statistical , Diffusion Tensor Imaging , Educational Status , Female , Hippocampus/anatomy & histology , Humans , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Male , Mental Recall/physiology , Middle Aged , Verbal Learning/physiology
10.
Neurology ; 78(19): 1456-63, 2012 May 08.
Article in English | MEDLINE | ID: mdl-22551732

ABSTRACT

OBJECTIVE: To investigate whether dementia incidence has changed over the last 2 decades. METHODS: We compared dementia incidence in 2 independent subcohorts of persons aged 60-90 years from the Rotterdam Study, a population-based cohort study. The first subcohort started in 1990 (n = 5,727), the second in 2000 (n = 1,769). Participants were dementia-free at baseline and followed for at maximum 5 years. We calculated age-adjusted dementia incidence rates for the 2 subcohorts in total, in 10-year age strata, and for men and women separately. We also compared mortality rates, differences in prevalence of vascular risk factors, and medication use. Finally, we compared brain volumes and the extent of cerebral small vessel disease in participants who underwent brain imaging 5 years after the baseline examinations. RESULTS: In the 1990 subcohort (25,696 person-years), 286 persons developed dementia, and in the 2000 subcohort (8,384 person-years), 49 persons. Age-adjusted dementia incidence rates were consistently, yet nonsignificantly, lower in the 2000 subcohort in all strata, reaching borderline significance in the overall analysis (incidence rate ratio 0.75, 95% confidence interval [CI] 0.56-1.02). Mortality rates were also lower in the 2000 subcohort (rate ratio 0.63, 95% CI 0.52-0.77). The prevalence of hypertension and obesity significantly increased between 1990 and 2000. This was paralleled by a strong increase in use of antithrombotics and lipid-lowering drugs. Participants in 2005-2006 had larger total brain volumes (p < 0.001) and less cerebral small vessel disease (although nonsignificant in men) than participants in 1995-1996. CONCLUSIONS: Although the differences in dementia incidence were nonsignificant, our study suggests that dementia incidence has decreased between 1990 and 2005.


Subject(s)
Dementia/epidemiology , Age Distribution , Aged , Aged, 80 and over , Female , Humans , Incidence , Male , Middle Aged , Prevalence , Sex Distribution
11.
Neurology ; 78(5): 326-33, 2012 Jan 31.
Article in English | MEDLINE | ID: mdl-22262748

ABSTRACT

OBJECTIVE: Cerebral microbleeds are frequently found in the general elderly population and may reflect underlying vascular disease, but their role in cognitive function is unknown. METHODS: We investigated the association between cerebral microbleeds and performance in multiple cognitive domains in 3,979 persons without dementia (mean age, 60.3 years). Mini-Mental State Examination (MMSE) score and neuropsychological tests were used to assess global cognition and the following cognitive domains: memory, information processing speed, executive function, and motor speed. We used number of microbleeds as continuous variable, and additionally distinguished between persons with no microbleeds, 1 microbleed, 2-4 microbleeds, and ≥5 microbleeds. The association of microbleeds with different cognitive domains was estimated using linear regression models. Additional adjustments were made for vascular risk factors, brain atrophy, and other imaging markers of cerebral small vessel disease. We stratified analyses by location of microbleeds. RESULTS: A higher number of microbleeds was associated with lower MMSE score and worse performance on tests of information processing speed and motor speed. When analyzed per category, presence of 5 or more microbleeds was associated with worse performance in all cognitive domains, except memory. These associations were most robust in participants with strictly lobar microbleeds, whereas after additional adjustments associations disappeared for deep or infratentorial microbleeds. CONCLUSIONS: Presence of numerous microbleeds, especially in a strictly lobar location, is associated with worse performance on tests measuring cognitive function, even after adjustments for vascular risk factors and other imaging markers of small vessel disease. These results suggest an independent role for microbleed-associated vasculopathy in cognitive impairment.


Subject(s)
Cerebral Hemorrhage/psychology , Cerebral Small Vessel Diseases/psychology , Cognition Disorders/psychology , Aged , Apolipoproteins E/genetics , Atrophy , Brain/pathology , Brain Infarction/pathology , Cerebral Hemorrhage/complications , Cerebral Hemorrhage/pathology , Cerebral Small Vessel Diseases/complications , Cerebral Small Vessel Diseases/pathology , Cognition Disorders/etiology , Cognition Disorders/pathology , Cohort Studies , Data Interpretation, Statistical , Educational Status , Female , Humans , Image Processing, Computer-Assisted , Linear Models , Magnetic Resonance Imaging , Male , Middle Aged , Neuropsychological Tests , Reaction Time/physiology , Risk Factors , Vascular Diseases/epidemiology , Vascular Diseases/pathology
12.
J Thromb Haemost ; 10(4): 550-6, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22257027

ABSTRACT

BACKGROUND: High von Willebrand factor (VWF) plasma levels are associated with an increased risk of stroke. VWF levels are strongly heritable. A previous meta-analysis of five large genome-wide association studies identified single-nucleotide polymorphisms (SNPs) within eight genetic loci as determinants of VWF levels. Whether these SNPs are associated with stroke risk is not known. The aim of our study was to investigate the association between genetic determinants of VWF levels and stroke risk. METHODS: The study was part of the Rotterdam Study, a large population-based cohort study among subjects aged ≥ 55 years. A total of 5763 participants for whom DNA was available, and who were free of stroke at baseline, were eligible for analysis. VWF antigen (VWF:Ag) levels were measured in 3379 eligible participants. Within each of the eight loci, one top SNP was defined. The association between the eight SNPs and the risk of stroke was analyzed. Then, a genetic score, based on these eight SNPs, was constructed, and its total contribution to VWF plasma levels and stroke risk was investigated. RESULTS: None of the eight SNPs was individually associated with stroke risk. A higher genetic score was significantly associated with a higher VWF:Ag level, but was not associated with an increased risk of stroke. CONCLUSION: Eight SNPs that strongly determine VWF levels are not associated with stroke risk, either individually, or combined in a genetic score.


Subject(s)
Polymorphism, Single Nucleotide , Stroke/blood , Stroke/genetics , von Willebrand Factor/analysis , von Willebrand Factor/genetics , Age Factors , Aged , Analysis of Variance , Biomarkers/blood , Female , Genetic Predisposition to Disease , Humans , Linear Models , Male , Middle Aged , Netherlands/epidemiology , Phenotype , Proportional Hazards Models , Prospective Studies , Risk Assessment , Risk Factors , Stroke/epidemiology , Time Factors , Up-Regulation
13.
Neurology ; 76(9): 816-21, 2011 Mar 01.
Article in English | MEDLINE | ID: mdl-21288987

ABSTRACT

BACKGROUND: Retinal vessels provide a unique opportunity to study both systemic and cerebrovascular disease. Smaller retinal arteriolar calibers are strongly related to hypertension, whereas larger retinal venular calibers are more related to inflammation, cerebral hypoperfusion, and cerebrovascular disease. Whether retinal vessel calibers are related to dementia remains unclear. METHODS: We investigated whether retinal arteriolar and venular calibers are associated with risk of dementia, and its subtypes Alzheimer disease (AD) and vascular dementia, in the prospective population-based Rotterdam Study. Digitized retinal images were available in 5,553 participants aged 55 years or over and dementia-free at baseline (1990-1993). Participants were re-examined in 1993-1994, 1997-1999, and 2002-2004 and were continuously monitored for development of dementia. RESULTS: During a mean follow-up of 11.6 years, 655 participants developed dementia. AD was diagnosed in 519 and vascular dementia in 73 participants. Larger venular calibers were associated with an increased risk of dementia, in particular vascular dementia (age- and sex-adjusted hazard ratio per SD increase: 1.31; 95% confidence interval 1.06-1.64), but not AD. The association remained significant after adjustment for stroke and cardiovascular risk factors. Smaller arteriolar calibers were also associated with an increased risk of vascular dementia, yet only when adjusted for venular calibers. CONCLUSIONS: Retinal venular widening is associated with an increased risk of vascular dementia. Our findings are in line with previous observations in stroke and cerebral small-vessel disease and suggest that the association between larger retinal venular calibers and dementia may reflect cerebral hypoperfusion and subsequent ischemia.


Subject(s)
Alzheimer Disease/epidemiology , Alzheimer Disease/pathology , Dementia, Vascular/epidemiology , Dementia, Vascular/pathology , Population Surveillance , Retinal Vessels/pathology , Aged , Aged, 80 and over , Cohort Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Netherlands/epidemiology , Population Surveillance/methods , Prospective Studies , Risk Factors
14.
Neurobiol Aging ; 32(9): 1607-14, 2011 Sep.
Article in English | MEDLINE | ID: mdl-19926167

ABSTRACT

Cathepsin D (CTSD) is a gene involved in amyloid precursor protein processing and is considered a candidate for Alzheimer's disease (AD). The aim of the current study was to examine if variation in CTSD increases the risk of AD. We performed a candidate-gene analysis in a population-based cohort study (N=7983), and estimated the effect of CTSD on the risk of AD. Additionally, a large meta-analysis was performed incorporating our data and previously published data. The T-allele of CTSD rs17571 was associated with an increased risk of AD (p-value 0.007) in the Rotterdam Study. This association was predominantly found in APOE ε4 noncarriers. A meta-analysis of previously published data showed a significantly increased risk of AD in carriers of the T-allele of rs17571 (OR 1.22, 95% CI 1.03-1.44), irrespective of APOE ε4 carrier status. This study adds to the evidence that CTSD increases the risk of AD, although the effect size is moderate.


Subject(s)
Alzheimer Disease/epidemiology , Alzheimer Disease/genetics , Cathepsin D/genetics , Genetic Predisposition to Disease/epidemiology , Genetic Predisposition to Disease/genetics , Aged , Aged, 80 and over , Case-Control Studies , Cohort Studies , Evidence-Based Medicine/trends , Female , Humans , Longitudinal Studies , Male , Polymorphism, Single Nucleotide/genetics , Risk Factors
15.
J Neurol Neurosurg Psychiatry ; 82(1): 41-4, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20667857

ABSTRACT

BACKGROUND: Asymptomatic cerebral lesions on MRI such as white matter lesions (WML), lacunes and microbleeds are commonly seen in older people. We examined the role of a series of candidate genes involved in blood pressure regulation and amyloid metabolism. MATERIALS AND METHODS: The study was embedded in a family-based cohort sampled from a Dutch genetically isolated population. We selected individuals between 55 and 75 years of age with hypertension (N=129). Volumes of WML and presence of lacunes and microbleeds were assessed with MRI. We studied three genes involved in blood pressure regulation (angiotensin, angiotensin II type 1 receptor, α-adducin) and two genes involved in the amyloid pathway (apolipoprotein E (APOE) and sortilin-related receptor gene (SORL1)). RESULTS: All participants had WML (median volume, 3.1 ml; interquartile range, 1.5-6.5 ml); lacunar infarcts were present in 15.5% and microbleeds in 23.3%. Homozygosity for the APOE ε4 allele was associated with lacunes (OR, 4.8; 95% CI, 1.2 to 19.3). Individuals carrying two copies of the variant allele of four single nucleotide polymorphism (SNPs) located at the 3'-end of SORL1 (rs1699102, rs3824968, rs2282649, rs1010159) had significantly more often microbleeds (highest OR, 6.87; 95% CI, 1.78 to 26.44). CONCLUSION: The association of SORL1 with microbleeds suggests that the amyloid cascade is involved in the aetiology of microbleeds in populations with hypertension.


Subject(s)
Cerebrovascular Disorders/epidemiology , Cerebrovascular Disorders/genetics , Hypertension/epidemiology , Hypertension/genetics , Aged , Amyloid/genetics , Amyloid/metabolism , Apolipoproteins E/genetics , Blood Pressure/physiology , Calmodulin-Binding Proteins/genetics , Cerebral Hemorrhage/etiology , Cerebral Hemorrhage/pathology , Cerebrovascular Disorders/etiology , Cognition Disorders/etiology , Cognition Disorders/psychology , Cohort Studies , Female , Genotype , Humans , Hypertension/complications , LDL-Receptor Related Proteins/genetics , Magnetic Resonance Imaging , Male , Membrane Transport Proteins/genetics , Middle Aged , Netherlands/epidemiology , Neuropsychological Tests , Polymorphism, Single Nucleotide/genetics , Receptor, Angiotensin, Type 1/genetics
16.
Neurology ; 75(22): 1982-7, 2010 Nov 30.
Article in English | MEDLINE | ID: mdl-21115952

ABSTRACT

OBJECTIVE: Diabetes mellitus has been associated with an increased risk of Alzheimer disease (AD), but how it exerts its effect remains controversial. Possible pathophysiologic mechanisms are glucose toxicity and a direct effect of insulin on amyloid metabolism. Most studies had short follow-up, and longer-term effects of diabetes on AD risk are unknown. We investigated whether fasting glucose and insulin levels and insulin resistance are associated with the risk of AD and whether this risk is constant over time. METHODS: The study was based on 3,139 participants of the Rotterdam Study, a population-based cohort study. All subjects were free from dementia, did not have a history of diabetes, and had fasting levels of glucose and insulin measured at baseline. Insulin resistance was estimated with the homeostasis model assessment. We investigated how fasting glucose, insulin, and insulin resistance are related to the risk of AD in 3 different strata according to time-to-event, using Cox proportional hazards models. RESULTS: During follow-up, 211 participants developed AD, 71 of them within 3 years of baseline. Levels of insulin and insulin resistance were associated with a higher risk of AD within 3 years of baseline. After 3 years, the risk was no longer increased. Glucose was not associated with a higher risk of AD. There was no interaction of APOE ε4 carriership and insulin metabolism on the risk of AD. CONCLUSIONS: Our findings suggest that insulin metabolism influences the clinical manifestation of AD only within 3 years.


Subject(s)
Alzheimer Disease/etiology , Blood Glucose/metabolism , Insulin Resistance , Insulin/metabolism , Aged , Aged, 80 and over , Alleles , Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Apolipoprotein E4/genetics , Cohort Studies , Female , Genotype , Humans , Male , Middle Aged , Proportional Hazards Models , Risk
17.
Eur J Epidemiol ; 25(11): 807-12, 2010 Nov.
Article in English | MEDLINE | ID: mdl-21061046

ABSTRACT

Patients with heart failure used to have an increased risk of stroke, but this may have changed with current treatment regimens. We assessed the association between heart failure and the risk of stroke in a population-based cohort that was followed since 1990. The study uses the cohort of the Rotterdam Study and is based on 7,546 participants who at baseline (1990­1993) were aged 55 years or over and free from stroke. The associations between heart failure and risk of stroke were assessed using time-dependent Cox proportional hazards models, adjusted for cardiovascular risk factors (smoking, diabetes mellitus, BMI, ankle brachial index, blood pressure, atrial fibrillation, myocardial infarction and relevant medication). At baseline, 233 participants had heart failure. During an average follow-up time of 9.7 years, 1,014 persons developed heart failure, and 827 strokes (470 ischemic, 75 hemorrhagic, 282 unclassified) occurred. The risk of ischemic stroke was more than five-fold increased in the first month after diagnosis of heart failure (age and sex adjusted HR 5.79, 95% CI 2.15­15.62), but attenuated over time (age and sex adjusted HR 3.50 [95% CI 1.96­6.25] after 1­6 months and 0.83 [95% CI 0.53­1.29] after 0.5­6 years). Additional adjustment for cardiovascular risk factors only marginally attenuated these risks. In conclusion, the risk of ischemic stroke is strongly increased shortly after the diagnosis of heart failure but returns to normal within 6 months after onset of heart failure.


Subject(s)
Heart Failure/complications , Stroke/epidemiology , Aged , Cohort Studies , Female , Humans , Male , Middle Aged , Netherlands/epidemiology , Proportional Hazards Models , Prospective Studies , Risk Assessment , Stroke/etiology
19.
J Hum Hypertens ; 24(2): 86-92, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19494836

ABSTRACT

This study was performed to examine the association of cardiovascular risk factors with calcification in the coronary arteries, aortic arch and carotid arteries, assessed by multislice computed tomography (MSCT). This study was embedded in the Rotterdam Study, a population-based study in subjects aged 55 years and over. From October 2003 until December 2004, subjects were invited to undergo a MSCT scan. Coronary, aortic arch and carotid calcification were quantified according to the Agatston score. Analyses were performed in the first 1003 subjects. Age and current smoking were the strongest independent risk factors for arterial calcification. The odds ratio (OR) for age in women, irrespective of the vessel bed, was 1.1 (P<0.001) and in men it was 1.2 with aortic arch and 1.1 with carotid calcification (both P<0.001). Current smoking was associated with aortic arch calcification with an OR of 3.5 in women and of 4.7 in men (both P<0.001); and with carotid calcification with an OR of 2.1 in women (P<0.05) and of 4.1 in men (P<0.01). Hypertension, hypercholesterolemia and diabetes were also independently related to calcification, although not consistent across all vessel beds and for men and women. Obesity tended to be inversely related to arterial calcification in women, whereas low high-density lipoprotein-cholesterol showed no relation with arterial calcification. In conclusion, although associations were not completely consistent across the different vessel beds and for men and women, our results indicate that generally the same risk factors are present for atherosclerosis in the coronary, aortic arch and carotid circulation.


Subject(s)
Aorta, Thoracic , Aortic Diseases/etiology , Calcinosis/etiology , Carotid Artery Diseases/etiology , Coronary Artery Disease/etiology , Age Factors , Aged , Aorta, Thoracic/diagnostic imaging , Aortic Diseases/diagnostic imaging , Aortic Diseases/epidemiology , Aortography/methods , Calcinosis/diagnostic imaging , Calcinosis/epidemiology , Carotid Artery Diseases/diagnostic imaging , Carotid Artery Diseases/epidemiology , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/epidemiology , Diabetes Complications/etiology , Female , Humans , Hypercholesterolemia/complications , Hypertension/complications , Logistic Models , Male , Middle Aged , Netherlands/epidemiology , Obesity/complications , Odds Ratio , Population Surveillance , Risk Assessment , Risk Factors , Sex Factors , Smoking/adverse effects , Tomography, X-Ray Computed
20.
Neurology ; 73(3): 202-5, 2009 Jul 21.
Article in English | MEDLINE | ID: mdl-19620607

ABSTRACT

BACKGROUND: Superficial siderosis is a rare radiologic diagnosis of hemosiderin deposition in subpial brain layers. In case studies, an association between superficial siderosis and cerebral amyloid angiopathy (CAA) has been described. Also, a potential role of superficial siderosis in Alzheimer disease (AD) was hypothesized. All previously reported cases of superficial siderosis were detected because of overt clinical symptoms. We studied the occurrence of superficial siderosis on brain MRI in a general population of nondemented elderly. METHODS: In 1,062 persons (mean age 69.6 years) from the population-based Rotterdam Scan Study, we performed T2*-weighted MRI to assess the presence of superficial siderosis. Furthermore, the presence, number, and location of cerebral microbleeds were rated, as lobar microbleeds are thought to be indicative of CAA. RESULTS: We found that superficial siderosis was present in 7 (0.7%) individuals, all of whom had cerebral microbleeds in lobar locations. Furthermore, in all 7 persons, microbleeds were located in close vicinity to superficial siderosis. CONCLUSIONS: Our results provide further indirect support for the presumed link between superficial siderosis and cerebral amyloid angiopathy (CAA). Whether superficial siderosis may be a marker for severity or worse prognosis of CAA needs to be further evaluated in longitudinal follow-up.


Subject(s)
Cerebral Amyloid Angiopathy/epidemiology , Cerebral Amyloid Angiopathy/pathology , Siderosis/epidemiology , Siderosis/pathology , Subarachnoid Hemorrhage/epidemiology , Subarachnoid Hemorrhage/pathology , Aged , Aged, 80 and over , Alzheimer Disease/epidemiology , Alzheimer Disease/pathology , Alzheimer Disease/physiopathology , Biomarkers/analysis , Biomarkers/metabolism , Brain/blood supply , Brain/pathology , Brain/physiopathology , Cerebral Amyloid Angiopathy/physiopathology , Cerebral Arteries/pathology , Cerebral Arteries/physiopathology , Cohort Studies , Disease Progression , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Predictive Value of Tests , Prevalence , Prognosis , Siderosis/physiopathology , Subarachnoid Hemorrhage/physiopathology , Subarachnoid Space/pathology , Subarachnoid Space/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...